Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenmin Chen
Institution:
Guangzhou University of Chinese Medicine
Observed institution:
Guangzhou University of Chinese Medicine
ORCID:
0000-0002-2126-3112
Observed ORCID:
0000-0002-2126-3112
OpenAlex ID:
A5025781070
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study
2023
·
Wenmin Chen
, Jietao Lin
, et al.
·
Integrative Cancer Therapies
·
7
PDF
Posterior reversible encephalopathy syndrome associated with use of anlotinib to treat squamous cell carcinoma of the cervix: case report and literature review
2023
·
Jietao Lin
, Wenmin Chen
, et al.
·
Frontiers in Pharmacology
·
2
PDF
Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort)
2023
·
Jietao Lin
, Lingling Sun
, et al.
·
Integrative Cancer Therapies
·
2
PDF
Show more works
View as search
Works count:
3
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type